financetom
Business
financetom
/
Business
/
Coromandel International's CFO expects a reduction in subsidy rates from the Indian govt
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Coromandel International's CFO expects a reduction in subsidy rates from the Indian govt
May 16, 2023 7:05 AM

Fertiliser maker Coromandel International on Monday reported a 15 percent year-on-year decrease in its net profit at Rs 246.4 crore for the fourth quarter (Q4FY23) that ended on March 31, 2023. It was Rs 290 crore in the same quarter a year ago. Revenue from operations during the fourth quarter rose 29.5 percent to Rs 5,475.8 crore, as against Rs 4,226.8 crore in the previous-year quarter.

Share Market Live

NSE

Jayashree Satagopan, President - Corporate & CFO, Coromandel International told CNBC-TV18 that the company has been seeing good margins and they are not sitting on any high cost inventory at this point in time.

She further added that the industry expects a reduction in subsidy rates from the government.

Also read: Coromandel International Q4 results: Net profit dips 15%; Rs 6 per share dividend announced

“Given the sharp reduction in the raw material prices that we have been witnessing over the past few months, we are expecting a reduction in the subsidy rates from the government. And this is likely to be done in two stages.

One as of first January 2023, and the other one first, April 2023. The NBS rates have not yet been announced and as management, we have taken our best estimates to factor in the reduction in subsidy rates and that probably is the reason for a slightly muted Q4 performance in terms of margins,” she added.

Additionally in February 2023, the Finance Minister of India, Nirmala

Sitharaman, revealed that the fertiliser subsidy for the current fiscal year has been raised to Rs 2.25 lakh crore, up from the budget estimate of Rs 1.05 lakh crore.

Looking at EBITDA per tonne of Rs 5,500-6,000 in FY24

She further mentioned that due to recent developments in the manufacturing facilities, they have to process multiple grades of raw material, the company expects to see higher EBITDA per tonne for FY 24.

“I think about Rs 5500-6000 per tonne would be a good number for us to look at on an annualised basis,” she added

Volume growth could be 5-10% in FY24

Coromandel International’s overall sale stood at Rs 5,475.8 crore in March 2023, up 29.5 percent on-year in volume terms. Satagopan added that the company’s overall sales volume has gone up by almost 10 percent. She Further mentioned that the volume growth could be anywhere between 5 to 10 percent depending upon how the season is going to come in for FY24.

Diversification plans

The Murugappa Group company announced in March that it has got Board approval to expand operations in crop protection chemicals, diversify into speciality and industrial chemicals and foray into contract development and manufacturing organisation (CDMO) business.

“We are looking into almost Rs 1,000 crore of investment that goes into diversification, setting up new multi-purpose plants primarily for the crop protection chemicals and also leveraging the competencies into speciality and industrial chemicals. We expect to see about Rs 2,000 to 3,000 crore of revenue to come from these assets over the next two to three year timeframe,” Satagopan added.

Also read: This analyst explains why he recommends buy calls on Axis Bank, NALCO, Balrampur Chini and Coromandel International

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merck to Start Phase 3 Trials of MK-8527 for HIV Prevention
Merck to Start Phase 3 Trials of MK-8527 for HIV Prevention
Jul 14, 2025
10:00 AM EDT, 07/14/2025 (MT Newswires) -- Merck ( MRK ) said Monday it plans to start a program of phase 3 trials to evaluate the safety and efficacy of MK-8527, the company's investigational once-monthly oral nucleoside reverse transcriptase translocation inhibitor for HIV pre-exposure prophylaxis. The company said the EXPrESSIVE-11 phase 3 trial will evaluate MK-8527 in people with greater...
Robinhood Markets Unusual Options Activity
Robinhood Markets Unusual Options Activity
Jul 14, 2025
Investors with a lot of money to spend have taken a bearish stance on Robinhood Markets ( HOOD ) . And retail traders should know. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this...
Matador Technologies Files Preliminary Base Shelf Prospectus for $900 Million
Matador Technologies Files Preliminary Base Shelf Prospectus for $900 Million
Jul 14, 2025
10:06 AM EDT, 07/14/2025 (MT Newswires) -- Matador Technologies ( MATAF ) on Monday said it filed a preliminary short form base shelf prospectus for up to $900 million with the securities commissions in all Canadian provinces except Quebec. If approved by regulators, the shelf prospectus will allow the company to issue over a 25-month period up to $900 million...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved